Evaluation of the Long-Term Impact on Quality After the End of Pharmacist-Driven Warfarin Therapy Management in Patients With Poor Quality of Anticoagulation Therapy

• Главные авторы: Leiliane Rodrigues Marcatto (Автор), Luciana Sacilotto (Автор), Letícia Camargo Tavares (Автор), Debora Stephanie Pereira Souza (Автор), Natália Olivetti (Автор), Celia Maria Cassaro Strunz (Автор), Francisco Carlos Costa Darrieux (Автор), Maurício Ibrahim Scanavacca (Автор), Jose Eduardo Krieger (Автор), Alexandre Costa Pereira (Автор), Paulo Caleb Junior Lima Santos (Автор)
• Формат: ‌
• Опубликовано: Frontiers Media S.A., 2020-07-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

BackgroundWarfarin is the most common oral anticoagulant drug, especially in low-income and emerging countries, because of the high cost of direct oral anticoagulant (DOACs), or when warfarin is the only proven therapy (mechanical prosthetic valve and kidney dysfunction). The quality of warfarin the...